The Swiss pharmaceutical company reiterated its outlook, predicting single-digit growth this year, following an end to the slump in COVID-19-related sales.
Roche prepares for business after boom from COVID-related products
Read Next
- Supreme Court lets Trump fire FTC’s Slaughter for now
- NikeSKIMS activewear line to launch this week
- Michelob Ultra overtakes Modelo Especial as best-selling U.S. beer
- Mamdani drops ABC event, Hollywood stars pen letter
- Bitcoin (BTC) Surges Amid Federal Reserve Rate Cut and Market Volatility
- Spirit Airlines to furlough 1,800 flight attendants to cost cuts
- SEC charges North Carolina man with conducting fraudulent “free-riding” scheme
